Silverarc Capital Management »

Novo Nordisk A/S shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $5.5M 60k 90.94

More positions owned by Silverarc Capital Management

ImmunoGen Long Option Calls Call Option
SPRD S&P Biotech ETF Long Option Calls Call Option (XBI)
Akero Therapeutics Long Option Calls Call Option (AKRO)
Mirati Therapeutics Long Option Calls Call Option
Morphic Holding Equities (MORF)
Merus NV Equities (MRUS)
CymaBay Therapeutics Long Option Calls Call Option
Soleno Therapeutics Equities (SLNO)
Intra-Cellular Therapies Equities (ITCI)
Poseida Therapeutics Equities (PSTX)
Krystal Biotech Equities (KRYS)
Mersana Therapeutics Long Option Calls Call Option (MRSN)
KalVista Pharmaceuticals Long Option Calls Call Option (KALV)
Biogen Idec Equities (BIIB)
Urogen Pharma Equities (URGN)

View all positions for Silverarc Capital Management

Top funds holding Novo Nordisk A/S

Jennison Associates
Fisher Investments
Bank of America Corporation
Fayez Sarofim & Co
Folketrygdfondet
Polen Capital Management
T. Rowe Price Associates
Everett Harris & Co
State Farm Mutual Automobile Insurance Company
Goldman Sachs Group
Jpmorgan Chase & Co
WCM Investment Management
Sustainable Growth Advisers
Wells Fargo & Company
Royal Bank of Canada

View all funds holding Novo Nordisk A/S